Betadexamine Tablets 0,25 mg/2 mg Tablets.
PDF Leaflet Revision Date: 14 November 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of acute allergic rhinitis and steroid-responsive dermatological allergies.
Dosage (summary)
1-2 tablets four times daily after meals; max 8 tablets/day; treatment u2264 5 days.
Onset of Action / Duration
Onset: 30-60 mins, Duration: 4-8 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety not established; may affect fetal development; caution in breastfeeding.
Key Drug Interactions
- MAOIs (increased CNS effects)
- Warfarin (increased PTT)
- NSAIDs (increased ulcerogenic effect)
Contraindications
- Hypersensitivity to components
- Systemic infections
- New-borns and premature infants
Common side effects
- Drowsiness
- Increased infection risk
- Hypertension
Counselling Points
- Avoid driving if drowsy
- Limit alcohol intake
- Monitor for signs of infection
Serious warnings
- Risk of myocardial rupture post-MI
- Avoid live vaccines
- Caution in immunosuppressed patients
Important Disclaimer
The Betadexamine Tablets 0,25 mg/2 mg Tablets. professional information leaflet below is the property of Pharmacare Limited and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
